Literature DB >> 29397541

Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study.

Siavash Piran1,2, Hugh Traquair3, Noel Chan3, Marlene Robinson3, Sam Schulman3.   

Abstract

Anticoagulant-related nephropathy is an acute kidney injury (AKI) associated with excessive anticoagulation. The nature of the association between excessive anticoagulation with warfarin and AKI and its incidence remain unclear. To evaluate the incidence of AKI in excessively anticoagulated patients taking warfarin and examine potential risk factors. A retrospective chart review was performed in patients on chronic warfarin. The primary outcome was AKI, defined as an acute increase in creatinine of > 26.5 µmol/L within 7-14 days of an international normalized ratio (INR) ≥ 4.0. 292 patients with an INR ≥ 4.0 were included. 101 patients had CKD and 191 did not have CKD. Of the 292 patients with an INR ≥ 4.0, 38 (13%) had an AKI. In univariable analyses, CKD [odds ratio (OR) 2.1, 95% confidence interval (CI) 0.99-4.43] and use of renin-angiotensin system (RAS) blockers and/or diuretics (OR 3.85; 95% CI 1.15-20.15) were significantly associated with the risk of AKI. In a binomial logistic regression model, use of RAS blockers and/or diuretics was the only significant predictor of AKI (OR 3.4; 95% CI 1.02-11.76). Use of RAS blockers and/or diuretics significantly increased the risk of AKI in patients with warfarin-related excessive anticoagulation. Further prospective studies examining the association of high INRs and AKI are needed.

Entities:  

Keywords:  Acute kidney injury; Anticoagulants; Creatinine, international normalized ratio; Warfarin

Mesh:

Substances:

Year:  2018        PMID: 29397541     DOI: 10.1007/s11239-018-1626-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  14 in total

1.  Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation.

Authors:  Kyle Ware; Polina Brodsky; Anjali A Satoskar; Tibor Nadasdy; Gyongyi Nadasdy; Haifeng Wu; Brad H Rovin; Udayan Bhatt; Jon Von Visger; Lee A Hebert; Sergey V Brodsky
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

2.  Warfarin-related nephropathy: another newly recognized complication of an old drug.

Authors:  Dana V Rizk; David G Warnock
Journal:  Kidney Int       Date:  2011-07       Impact factor: 10.612

3.  5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy.

Authors:  A Ozcan; K Ware; E Calomeni; T Nadasdy; R Forbes; A A Satoskar; G Nadasdy; B H Rovin; L A Hebert; S V Brodsky
Journal:  Am J Nephrol       Date:  2012-04-02       Impact factor: 3.754

4.  Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats.

Authors:  Margaret Ryan; Kyle Ware; Zahida Qamri; Anjali Satoskar; Haifeng Wu; Gyongyi Nadasdy; Brad Rovin; Lee Hebert; Tibor Nadasdy; Sergey V Brodsky
Journal:  Nephrol Dial Transplant       Date:  2013-09-05       Impact factor: 5.992

5.  Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.

Authors:  Sergey V Brodsky; Tibor Nadasdy; Brad H Rovin; Anjali A Satoskar; Gyongyi M Nadasdy; Haifeng M Wu; Udayan Y Bhatt; Lee A Hebert
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

6.  Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease.

Authors:  Sergey V Brodsky; Michael Collins; Edward Park; Brad H Rovin; Anjali A Satoskar; Gyongyi Nadasdy; Haifeng Wu; Udayan Bhatt; Tibor Nadasdy; Lee A Hebert
Journal:  Nephron Clin Pract       Date:  2010-04-22

7.  Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.

Authors:  Russell Berger; Steven D Salhanick; Maureen Chase; Michael Ganetsky
Journal:  Ann Emerg Med       Date:  2013-04       Impact factor: 5.721

8.  Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.

Authors:  Sergey V Brodsky; Anjali Satoskar; Jun Chen; Gyongyi Nadasdy; Jeremiah W Eagen; Mirza Hamirani; Lee Hebert; Edward Calomeni; Tibor Nadasdy
Journal:  Am J Kidney Dis       Date:  2009-07-04       Impact factor: 8.860

Review 9.  Anticoagulation-related nephropathy.

Authors:  D S Wheeler; R P Giugliano; J Rangaswami
Journal:  J Thromb Haemost       Date:  2016-02-15       Impact factor: 5.824

10.  Anticoagulant-Related Nephropathy: Is an AKI Elephant Hiding in Plain View?

Authors:  Sergey V Brodsky; Lee A Hebert
Journal:  J Am Coll Cardiol       Date:  2016-11-29       Impact factor: 24.094

View more
  4 in total

1.  Anticoagulant-Related Nephropathy: It's the Real McCoy.

Authors:  Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-21       Impact factor: 8.237

Review 2.  Role of direct oral anticoagulants in patients with kidney disease.

Authors:  Vimal K Derebail; Michelle N Rheault; Bryce A Kerlin
Journal:  Kidney Int       Date:  2019-12-24       Impact factor: 10.612

3.  Anticoagulant-related nephropathy: a pathological note.

Authors:  Vincenzo L'Imperio; Alessia Guarnieri; Federico Pieruzzi; Renato Alberto Sinico; Fabio Pagni
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

4.  Anticoagulant-Related Nephropathy in Kidney Biopsy: A Single-Center Report of 41 Cases.

Authors:  Sergey V Brodsky; Anjali Satoskar; Jessica Hemminger; Brad Rovin; Lee Hebert; Margaret S Ryan; Tibor Nadasdy
Journal:  Kidney Med       Date:  2019-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.